MARR SPA (MARR.MI) Fundamental Analysis & Valuation

BIT:MARR • IT0003428445

Current stock price

7.83 EUR
-0.09 (-1.14%)
Last:

This MARR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MARR.MI Profitability Analysis

1.1 Basic Checks

  • MARR had positive earnings in the past year.
  • MARR had a positive operating cash flow in the past year.
  • In the past 5 years MARR has always been profitable.
  • MARR had a positive operating cash flow in 4 of the past 5 years.
MARR.MI Yearly Net Income VS EBIT VS OCF VS FCFMARR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • With a Return On Assets value of 3.94%, MARR perfoms like the industry average, outperforming 43.48% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 15.95%, MARR is in the better half of the industry, outperforming 60.87% of the companies in the same industry.
  • The Return On Invested Capital of MARR (9.21%) is better than 65.22% of its industry peers.
Industry RankSector Rank
ROA 3.94%
ROE 15.95%
ROIC 9.21%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MARR.MI Yearly ROA, ROE, ROICMARR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • The Profit Margin of MARR (1.71%) is worse than 60.87% of its industry peers.
  • MARR's Profit Margin has improved in the last couple of years.
  • MARR has a worse Operating Margin (3.04%) than 65.22% of its industry peers.
  • MARR's Operating Margin has improved in the last couple of years.
  • MARR has a worse Gross Margin (8.00%) than 91.30% of its industry peers.
  • In the last couple of years the Gross Margin of MARR has remained more or less at the same level.
Industry RankSector Rank
OM 3.04%
PM (TTM) 1.71%
GM 8%
OM growth 3Y10.28%
OM growth 5Y139.42%
PM growth 3Y1.89%
PM growth 5YN/A
GM growth 3Y-1.71%
GM growth 5Y1.18%
MARR.MI Yearly Profit, Operating, Gross MarginsMARR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

5

2. MARR.MI Health Analysis

2.1 Basic Checks

  • MARR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • MARR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MARR.MI Yearly Shares OutstandingMARR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MARR.MI Yearly Total Debt VS Total AssetsMARR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 3.39 indicates that MARR is not in any danger for bankruptcy at the moment.
  • MARR's Altman-Z score of 3.39 is fine compared to the rest of the industry. MARR outperforms 69.57% of its industry peers.
  • The Debt to FCF ratio of MARR is 19.52, which is on the high side as it means it would take MARR, 19.52 years of fcf income to pay off all of its debts.
  • MARR has a worse Debt to FCF ratio (19.52) than 73.91% of its industry peers.
  • MARR has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
  • MARR has a Debt to Equity ratio of 1.06. This is comparable to the rest of the industry: MARR outperforms 43.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 19.52
Altman-Z 3.39
ROIC/WACC1.38
WACC6.66%
MARR.MI Yearly LT Debt VS Equity VS FCFMARR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.47 indicates that MARR should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.47, MARR belongs to the top of the industry, outperforming 86.96% of the companies in the same industry.
  • A Quick Ratio of 1.07 indicates that MARR should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.07, MARR belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.07
MARR.MI Yearly Current Assets VS Current LiabilitesMARR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. MARR.MI Growth Analysis

3.1 Past

  • MARR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.31%.
  • MARR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.87% yearly.
  • The Revenue has grown by 33.70% in the past year. This is a very strong growth!
  • The Revenue has been growing by 14.60% on average over the past years. This is quite good.
EPS 1Y (TTM)-5.31%
EPS 3Y6.87%
EPS 5YN/A
EPS Q2Q%26.65%
Revenue 1Y (TTM)33.7%
Revenue growth 3Y3.32%
Revenue growth 5Y14.6%
Sales Q2Q%92.94%

3.2 Future

  • MARR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.81% yearly.
  • Based on estimates for the next years, MARR will show a small growth in Revenue. The Revenue will grow by 3.89% on average per year.
EPS Next Y21.97%
EPS Next 2Y17.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.42%
Revenue Next 2Y2.91%
Revenue Next 3Y2.63%
Revenue Next 5Y3.89%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MARR.MI Yearly Revenue VS EstimatesMARR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
MARR.MI Yearly EPS VS EstimatesMARR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

7

4. MARR.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 8.51, which indicates a very decent valuation of MARR.
  • Based on the Price/Earnings ratio, MARR is valued cheaply inside the industry as 95.65% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.21. MARR is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 10.99, the valuation of MARR can be described as very reasonable.
  • 82.61% of the companies in the same industry are more expensive than MARR, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.10, MARR is valued rather cheaply.
Industry RankSector Rank
PE 8.51
Fwd PE 10.99
MARR.MI Price Earnings VS Forward Price EarningsMARR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MARR indicates a somewhat cheap valuation: MARR is cheaper than 78.26% of the companies listed in the same industry.
  • MARR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 21.81
EV/EBITDA 6.58
MARR.MI Per share dataMARR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • MARR's earnings are expected to grow with 17.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y17.81%
EPS Next 3YN/A

6

5. MARR.MI Dividend Analysis

5.1 Amount

  • MARR has a Yearly Dividend Yield of 6.45%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.75, MARR pays a better dividend. On top of this MARR pays more dividend than 86.96% of the companies listed in the same industry.
  • MARR's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 6.45%

5.2 History

  • The dividend of MARR decreases each year by -5.06%.
Dividend Growth(5Y)-5.06%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 73.12% of the earnings are spent on dividend by MARR. This is not a sustainable payout ratio.
DP73.12%
EPS Next 2Y17.81%
EPS Next 3YN/A
MARR.MI Yearly Income VS Free CF VS DividendMARR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M 100M
MARR.MI Dividend Payout.MARR.MI Dividend Payout, showing the Payout Ratio.MARR.MI Dividend Payout.PayoutRetained Earnings

MARR.MI Fundamentals: All Metrics, Ratios and Statistics

MARR SPA

BIT:MARR (4/7/2026, 5:35:15 PM)

7.83

-0.09 (-1.14%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)03-17
Earnings (Next)05-15
Inst Owners24.06%
Inst Owner ChangeN/A
Ins Owners50.42%
Ins Owner ChangeN/A
Market Cap520.93M
Revenue(TTM)4.07B
Net Income(TTM)52.62M
Analysts73.33
Price Target10.13 (29.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.45%
Yearly Dividend0.6
Dividend Growth(5Y)-5.06%
DP73.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.74%
PT rev (3m)-14.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-0.62%
Valuation
Industry RankSector Rank
PE 8.51
Fwd PE 10.99
P/S 0.17
P/FCF 21.81
P/OCF 9.17
P/B 1.58
P/tB 3.25
EV/EBITDA 6.58
EPS(TTM)0.92
EY11.75%
EPS(NY)0.71
Fwd EY9.1%
FCF(TTM)0.36
FCFY4.58%
OCF(TTM)0.85
OCFY10.91%
SpS46.22
BVpS4.96
TBVpS2.41
PEG (NY)0.39
PEG (5Y)N/A
Graham Number10.13
Profitability
Industry RankSector Rank
ROA 3.94%
ROE 15.95%
ROCE 13.34%
ROIC 9.21%
ROICexc 13.17%
ROICexgc 20.14%
OM 3.04%
PM (TTM) 1.71%
GM 8%
FCFM 0.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.28%
OM growth 5Y139.42%
PM growth 3Y1.89%
PM growth 5YN/A
GM growth 3Y-1.71%
GM growth 5Y1.18%
F-Score5
Asset Turnover2.3
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 19.52
Debt/EBITDA 2.94
Cap/Depr 129.56%
Cap/Sales 1.07%
Interest Coverage 4.6
Cash Conversion 47.79%
Profit Quality 45.39%
Current Ratio 1.47
Quick Ratio 1.07
Altman-Z 3.39
F-Score5
WACC6.66%
ROIC/WACC1.38
Cap/Depr(3y)116.01%
Cap/Depr(5y)95.38%
Cap/Sales(3y)1.3%
Cap/Sales(5y)1.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.31%
EPS 3Y6.87%
EPS 5YN/A
EPS Q2Q%26.65%
EPS Next Y21.97%
EPS Next 2Y17.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)33.7%
Revenue growth 3Y3.32%
Revenue growth 5Y14.6%
Sales Q2Q%92.94%
Revenue Next Year2.42%
Revenue Next 2Y2.91%
Revenue Next 3Y2.63%
Revenue Next 5Y3.89%
EBIT growth 1Y-20.86%
EBIT growth 3Y13.94%
EBIT growth 5Y174.37%
EBIT Next Year91.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.14%
OCF growth 3YN/A
OCF growth 5Y-9.51%

MARR SPA / MARR.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MARR SPA (MARR.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to MARR.MI.


What is the valuation status for MARR stock?

ChartMill assigns a valuation rating of 7 / 10 to MARR SPA (MARR.MI). This can be considered as Undervalued.


Can you provide the profitability details for MARR SPA?

MARR SPA (MARR.MI) has a profitability rating of 4 / 10.


What is the financial health of MARR SPA (MARR.MI) stock?

The financial health rating of MARR SPA (MARR.MI) is 5 / 10.


How sustainable is the dividend of MARR SPA (MARR.MI) stock?

The dividend rating of MARR SPA (MARR.MI) is 6 / 10 and the dividend payout ratio is 73.12%.